Yangkui Gu

Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study

Tianqi Zhang, Zhijun Geng, Mengxuan Zuo et al. · Signal Transduction and Targeted Therapy · 2023 · 122 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance

Lin Mei, Xiao-Long Zhang, Rui You et al. · Nature Communications · 2023 · 65 citations · Full text

Medicine, Evolutionary Biology, Oncology +17

Comparison between microwave ablation and lobectomy for stage I non-small cell lung cancer: a propensity score analysis

Yao Wang, Mingjian Lu, Wenzhe Fan et al. · International Journal of Hyperthermia · 2018 · 57 citations · Full text

Medicine, Oncology, Surgery +17

CT‐guided percutaneous microwave ablation of adrenal malignant carcinoma

Xin Li, Weijun Fan, Liang Zhang et al. · Cancer · 2011 · 55 citations · Full text

Medicine, Oncology, Surgery +16

Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations

Ming Zhao, Zhi Guo, Yinghua Zou et al. · Hepatology International · 2023 · 52 citations

Medicine, Hematology, Oncology +14